查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1883833

全球數位PCR市場

Digital PCRs
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到2030年，全球數位PCR市場規模將達到3.719億美元。

據估計，2024年全球數位PCR市場規模為2.345億美元，預計到2030年將達到3.719億美元，在分析期間（2024-2030年）內複合年成長率（CAGR）為8.0%。本報告分析的基礎研究應用領域預計複合年成長率為8.0%，到分析期末將達到1.507億美元。臨床診斷應用領域預計在分析期間內複合年成長率為8.5%。

美國市場規模估計為6,550萬美元，而中國市場預計將以7.5%的複合年成長率成長。

預計到2024年，美國數位PCR市場規模將達6,550萬美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到5,710萬美元，在2024年至2030年的分析期間內，複合年成長率（CAGR）為7.5%。其他值得關注的區域市場分析包括日本和加拿大，預計在分析期間內，這兩個國家的複合年成長率分別為7.5%和6.5%。在歐洲，德國預計將以約6.4%的複合年成長率成長。

全球數位PCR市場—主要市場趨勢與促進因素概述

什麼是數位PCR？為什麼說它是分子生物學領域的革命性技術？

數位PCR (dPCR) 是一種高精度、高靈敏度的分子技術，用於定量和擴增DNA或RNA。此技術將樣本分成多個獨立的反應體系。 PCR擴增後，分析每個反應體系，以確定目標序列的存在與否，從而提供比傳統PCR更精確的定量結果。數位PCR無需參考標準品或內參即可達到絕對定量。這顯著提高了檢測低表達標靶、評估基因表現量和分析遺傳變異的可靠性。該技術在臨床診斷、個人化醫療和環境生物學等領域尤其重要，因為在這些領域，精確測量至關重要。

科技進步如何提升數位PCR的性能？

近年來，數位PCR技術的進步體現在流體動態、微流體和軟體分析等方面，顯著提升了系統的精確度、易用性和通量。液滴數位PCR (ddPCR) 和晶片數位PCR (dPCR) 等創新技術透過增加分析區域的數量，提高了靈敏度和精確度，從而徹底革新了該領域。這些進步使得研究人員能夠以前所未有的精度檢測血液樣本中低濃度的腫瘤DNA等稀有DNA標靶。此外，自動化和即時數據分析軟體的整合降低了人為誤差的可能性，並簡化了工作流程。這些優勢使得數位PCR成為適用於高通量環境下常規應用的強大工具。

數位PCR技術將推動哪些應用？

除了基礎研究之外，數位PCR在許多應用領域的重要性日益凸顯。在臨床診斷中，它被用於早期檢測癌症突變和感染疾病、監測微量殘存疾病以及追蹤治療效果，從而直接影響患者的治療方案和預後。在環境監測中，數位PCR能夠檢測土壤和水樣本中低濃度的病原體和基因改造生物（GMO）。此外，在快速發展的液態生物檢體領域，它透過檢測和定量循環腫瘤DNA（ctDNA）來支持非侵入性癌症診斷，為早期診斷、預後評估和疾病監測提供了強力的工具。數位PCR的高靈敏度和高準確性使其在各個應用領域中得到應用，並推動其融入這些重要的研究和應用領域。

哪些因素正在推動數位PCR市場的成長？

數位PCR市場的成長受多種因素驅動，包括對精準分子診斷和個人化醫療日益成長的需求，而這些需求需要強大的定量技術。遺傳疾病和癌症的日益普遍，以及人們對液態生物檢體的認知不斷提高和臨床應用日益廣泛，進一步推動了對數位PCR技術的需求。提高數位PCR系統效率和降低成本的技術創新也促進了市場擴張。此外，數位PCR在食品安全、環境監測和農業生物學等領域的應用範圍不斷擴大，凸顯了其多功能性和有效性，吸引了來自各個領域的投資。這些因素，加上數位PCR系統的持續改善和對精準診斷日益成長的關注，有望推動數位PCR市場持續成長，體現其在分子生物學和臨床診斷未來發展中的重要作用。

部分：

產品（儀器、耗材、服務）、應用（基礎研究、臨床診斷、其他應用）、最終用途（研究機構、製藥公司、其他最終用途）

受訪公司範例

  • Bio-Rad Laboratories, Inc.
  • Fluidigm Corporation
  • Formulatrix
  • JN Medsys
  • RainDance Technologies, Inc.
  • Stilla Technologies
  • Thermo Fisher Scientific, Inc.

人工智慧整合

我們正在利用檢驗的專家內容和人工智慧工具來變革市場和競爭情報。

Market Glass, Inc. 並沒有採用查詢LLM 或產業專用的SLM 的典型方法，而是建立了一個由世界各地領域專家精心策劃的內容庫，其中包括影片轉錄、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

在最新發布的報告中，Market Glass, Inc. 將關稅對地理市場的影響納入考量，並根據公司總部所在地、製造地以及進出口（成品和OEM產品）情況，預測企業競爭地位的變化。這種複雜多變的市場現實會從多個方面影響競爭對手，包括增加銷貨成本、降低盈利和重組供應鏈，同時也會影響微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲
  • 亞太地區
  • 世界其他地區

第4章 競賽

簡介目錄
Product Code: MCP11555

Global Digital PCRs Market to Reach US$371.9 Million by 2030

The global market for Digital PCRs estimated at US$234.5 Million in the year 2024, is expected to reach US$371.9 Million by 2030, growing at a CAGR of 8.0% over the analysis period 2024-2030. Basic Research Application, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$150.7 Million by the end of the analysis period. Growth in the Clinical Diagnostics Application segment is estimated at 8.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$65.5 Million While China is Forecast to Grow at 7.5% CAGR

The Digital PCRs market in the U.S. is estimated at US$65.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$57.1 Million by the year 2030 trailing a CAGR of 7.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.5% and 6.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.4% CAGR.

Global Digital PCRs Market - Key Trends and Drivers Summarized

What Is Digital PCR and Why Is It a Game-Changer in Molecular Biology?

Digital PCR (dPCR) is a highly precise and sensitive molecular technique used to quantify and amplify DNA or RNA. This method partitions a sample into many individual reactions. After PCR amplification, each partition is analyzed to determine the presence or absence of the target sequence, allowing for more accurate quantification than traditional PCR methods. Digital PCR provides absolute quantification without the need for reference standards or internal controls, which significantly enhances its reliability for detecting low-abundance targets, assessing gene expression levels, and analyzing genetic variations. This technology is particularly valuable in clinical diagnostics, personalized medicine, and environmental biology, where precise measurements are crucial.

How Are Technological Advancements Refining Digital PCR Capabilities?

Recent technological advancements in digital PCR include improvements in fluid dynamics, microfluidics, and software analytics, which enhance the accuracy, usability, and throughput of these systems. Innovations such as droplet digital PCR (ddPCR) and chip-based dPCR have revolutionized the field by increasing the number of partitions analyzed, thereby providing greater sensitivity and precision. These advancements allow researchers to detect rare DNA targets, such as low-abundance tumor DNA in blood samples, with unprecedented accuracy. Furthermore, the integration of automation and real-time data analysis software reduces the potential for human error and streamlines the workflow, making digital PCR a robust tool for routine use in high-throughput settings.

What Applications Are Driven by Digital PCR Technology?

Digital PCR is becoming increasingly crucial across various applications beyond basic research. In clinical diagnostics, it is used for early detection of cancer mutations and infectious diseases, monitoring minimal residual disease, and tracking treatment efficacy, which can directly influence patient treatment plans and outcomes. In the field of environmental monitoring, dPCR enables the detection of low-levels of pathogens or GMOs in soil and water samples. Additionally, in the burgeoning field of liquid biopsy, dPCR helps in non-invasive cancer diagnostics by detecting and quantifying circulating tumor DNA, offering a powerful tool for early diagnosis, prognosis, and disease monitoring. Each application benefits from dPCR’s high sensitivity and precision, driving its integration into these critical areas of study and application.

What Drives the Growth in the Digital PCR Market?

The growth in the digital PCR market is driven by several factors, including the increasing demand for precise molecular diagnostics and personalized medicine, which require robust quantitative techniques. The rising prevalence of genetic disorders and cancer, coupled with growing awareness and clinical adoption of liquid biopsies, further fuels the demand for digital PCR technology. Technological innovations that enhance the efficiency and reduce the cost of dPCR setups also contribute to market expansion. Additionally, the broadening applications of dPCR in food safety, environmental monitoring, and agricultural biology emphasize its versatility and effectiveness, attracting investment from various sectors. These factors, combined with the ongoing improvements in digital PCR systems and a growing emphasis on precision diagnostics, ensure that the market for dPCR will continue to expand, reflecting its critical importance in the future of molecular biology and clinical diagnostics.

SCOPE OF STUDY:

The report analyzes the Digital PCRs market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Offering (Instruments, Consumables, Services); Application (Basic Research, Clinical Diagnostics, Other Applications); End-Use (Research Institutes, Pharmaceutical Companies, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 46 Featured) -

  • Bio-Rad Laboratories, Inc.
  • Fluidigm Corporation
  • Formulatrix
  • JN Medsys
  • RainDance Technologies, Inc.
  • Stilla Technologies
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Digital PCRs - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Precision Medicine Propels Adoption of Digital PCRs
    • Increasing Use of Digital PCR in Cancer Diagnostics Expands Market Opportunities
    • Expanding Applications of Digital PCR in Infectious Disease Testing Sets the Stage for Market Growth
    • Rising Adoption of Digital PCRs in Liquid Biopsy Technologies Drives Market Expansion
    • Increasing Use of Digital PCRs in Agricultural Biotechnology Bodes Well for Market Growth
    • Growing Focus on Non-Invasive Prenatal Testing (NIPT) Spurs Adoption of Digital PCRs
    • Growing Use of Digital PCR in Environmental Testing Expands Addressable Market
    • Expansion of Digital PCR in Food Safety Testing Generates Market Opportunities
    • Rising Prevalence of Genetic Disorders Sets the Stage for Growth in Digital PCR Market
    • Development of Portable Digital PCR Devices Bodes Well for Market Expansion
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Pharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Basic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Basic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Basic Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Clinical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Clinical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Clinical Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 28: World Digital PCRs Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Digital PCRs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Digital PCRs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Digital PCRs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Digital PCRs by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Digital PCRs by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Digital PCRs by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 118: Rest of Europe 15-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 121: Rest of Europe 15-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Europe 15-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 127: Asia-Pacific 15-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 130: Asia-Pacific 15-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 133: Asia-Pacific 15-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of World Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of World 15-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of World 15-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of World 15-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION